title: Rheumatic diseases should be actively treated in pregnancy, new guidelines say.
authors.affiliation: London.
authors.forename: Jacqui
authors.initials: J
authors.lastname: Wise
mesh_terms: D000068879:Adalimumab / Q000008:administration & dosage; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D000068582:Certolizumab Pegol / Q000627:therapeutic use; D000075202:Contraindications; D000068800:Etanercept / Q000008:administration & dosage; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use*; D006801:Humans; D008727:Methotrexate; D017410:Practice Guidelines as Topic; D011239:Prednisolone / Q000627:therapeutic use; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy*; D011263:Pregnancy Trimester, Third; D012216:Rheumatic Diseases / Q000188:drug therapy*
chemical_list: D018501:Antirheumatic Agents; D005938:Glucocorticoids; D011239:Prednisolone; D000068879:Adalimumab; D000068800:Etanercept; D000068582:Certolizumab Pegol; D008727:Methotrexate